Encephalopathy with myoclonic jerks resulting from ceftazidime therapy

An under-recognized potential side-effect when treating febrile neutropenia [3]

Research output: Contribution to journalLetter

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)413-414
Number of pages2
JournalLeukemia and Lymphoma
Volume48
Issue number2
DOIs
StatePublished - Feb 1 2007
Externally publishedYes

Fingerprint

Febrile Neutropenia
Myoclonus
Ceftazidime
Brain Diseases
Neutropenia
Anti-Bacterial Agents
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Hematology
  • Oncology

Cite this

@article{4a24547302db428aaeecf3d54eecafb8,
title = "Encephalopathy with myoclonic jerks resulting from ceftazidime therapy: An under-recognized potential side-effect when treating febrile neutropenia [3]",
author = "Michael Martin",
year = "2007",
month = "2",
day = "1",
doi = "10.1080/10428190601039755",
language = "English (US)",
volume = "48",
pages = "413--414",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Encephalopathy with myoclonic jerks resulting from ceftazidime therapy

T2 - An under-recognized potential side-effect when treating febrile neutropenia [3]

AU - Martin, Michael

PY - 2007/2/1

Y1 - 2007/2/1

UR - http://www.scopus.com/inward/record.url?scp=34247864017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247864017&partnerID=8YFLogxK

U2 - 10.1080/10428190601039755

DO - 10.1080/10428190601039755

M3 - Letter

VL - 48

SP - 413

EP - 414

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 2

ER -